Zhuo, Chao
Wei, Xiaolin
Zhang, Zhitong
Hicks, Joseph Paul
Zheng, Jinkun
Chen, Zhixu
Haldane, Victoria
Walley, John
Guan, Yubao
Xu, Hongyan
Zhong, Nanshan
Funding for this research was provided by:
Beijing Life Oasis Public Service Center (N/A)
Article History
Received: 19 February 2020
Accepted: 1 April 2020
First Online: 12 May 2020
Ethics approval and consent to participate
: the trial protocol has obtained ethical approval from the Office of Research Ethics at the University of Toronto (Ref: 38265) and the Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University (Ref: 2019–53). No consent form will be needed for prescription review. The Guangzhou Institute of Respiratory Health will seek written consent from each hospital under study. We will remove patient confidentialities such as names and national ID before the data is analysed. We will collect written consents but also allow verbal consent to be given by providers if requested for interviews, to protect people working in bureaucratic health systems, and to obtain as much objective information as much. All personally identifying information will be deleted before data entry using a unique study identification number assigned. Physical hard copies of the study data materials will be stored securely in a locked cabinet, separate from the data of other studies. For the qualitative data, only the researchers conducting the study will know the names of the participants, and have access to the responses from individual participants.
: Not applicable
: The authors declared that they have no competing interests.